Log in

NASDAQ:SBRASabra Health Care REIT Price Target & Analyst Ratings

-0.32 (-2.10 %)
(As of 08/14/2020 04:00 PM ET)
Today's Range
Now: $14.89
50-Day Range
MA: $14.41
52-Week Range
Now: $14.89
Volume886,497 shs
Average Volume2.38 million shs
Market Capitalization$3.06 billion
P/E Ratio23.64
Dividend Yield7.89%

Analyst Ratings

Sabra Health Care REIT (NASDAQ:SBRA) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
9 Wall Street analysts have issued ratings and price targets for Sabra Health Care REIT in the last 12 months. Their average twelve-month price target is $17.88, suggesting that the stock has a possible upside of 20.05%. The high price target for SBRA is $25.00 and the low price target for SBRA is $14.00. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score:
Ratings Breakdown: 1 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $17.88$17.88$18.21$22.40
Price Target Upside: 20.05% upside22.77% upside50.41% upside3.66% upside

Sabra Health Care REIT (NASDAQ:SBRA) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Sabra Health Care REIT (NASDAQ:SBRA) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/2/2020CitigroupBoost Price TargetNeutral$10.00 ➝ $14.00Low
6/23/2020ScotiabankUpgradeSector Underperform ➝ Sector Perform$12.00 ➝ $15.00Medium
6/22/2020Wells Fargo & CoBoost Price TargetEqual Weight$13.00 ➝ $14.00Low
6/8/2020JMP SecuritiesInitiated CoverageMarket PerformLow
5/18/2020Berenberg BankUpgradeHold ➝ Buy$15.00High
4/23/2020SunTrust BanksReiterated RatingHold$15.00Medium
3/23/2020Bank of AmericaDowngradeNeutral ➝ UnderperformMedium
2/26/2020MizuhoUpgradeNeutral ➝ Buy$22.00Low
2/6/2020BarclaysLower Price TargetOverweight$26.00 ➝ $25.00Low
2/26/2019BMO Capital MarketsDowngradeMarket Perform ➝ UnderperformMedium
11/16/2018Raymond JamesDowngradeOutperform ➝ Market PerformMedium
7/18/2018Jefferies Financial GroupReiterated Rating$21.91$22.00Low
6/4/2018Cantor FitzgeraldReiterated RatingBuy$25.00Medium
2/22/2018Stifel NicolausReiterated RatingHold ➝ Hold$22.00 ➝ $21.00Medium
9/25/2017Capital One FinancialInitiated CoverageEqual Weight$24.00Low
(Data available from 8/15/2018 forward)
This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.